Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023 -15.9% Revenue growth, 20233 Where the money goes Where each dollar of revenue went, fiscal 2023 Cost of revenue
Cost of revenue 80¢ $170.9M Research and development 10¢ $21.4M Other costs 9¢ $18.6M Income tax 1¢ $1.5M Out of $212.4M in revenue.3 4
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue5 6 7 8 3 $212.4M in 2023+40% since 2017 0 $100.0M $200.0M $300.0M 2017: $151.5M $151.5M 2017 2018: $162.7M $162.7M 2018 +7% 2019: $181.7M $181.7M 2019 +12% 2020: $147.7M $147.7M 2020 −19% 2021: $231.3M $231.3M 2021 +57% 2022: $252.4M $252.4M 2022 +9% 2023: $212.4M $212.4M 2023 −16% Gross profit9 6 7 8 3 $41.5M in 2023−52% since 2017 0 $50.0M $100.0M $150.0M 2017: $86.1M $86.1M 2017 2018: $80.4M $80.4M 2018 −7% 2019: $98.2M $98.2M 2019 +22% 2020: $75.8M $75.8M 2020 −23% 2021: $133.1M $133.1M 2021 +76% 2022: $139.8M $139.8M 2022 +5% 2023: $41.5M $41.5M 2023 −70% Operating income9 6 7 8 3 -$156.2M in 2023-$200.0M -$150.0M -$100.0M -$50.0M 0 $50.0M 2017: $11.1M $11.1M 2017 2018: -$13.4M -$13.4M 2018 2019: -$12.1M -$12.1M 2019 −10% 2020: -$22.8M -$22.8M 2020 +89% 2021: $1.8M $1.8M 2021 2022: -$38.2M -$38.2M 2022 2023: -$156.2M -$156.2M 2023 +309% Net income9 6 7 3 4 -$162.8M in 2023-$200.0M -$150.0M -$100.0M -$50.0M 0 $50.0M 2017: $30.0M $30.0M 2017 2018: -$30.8M -$30.8M 2018 2019: -$12.3M -$12.3M 2019 −60% 2020: -$23.9M -$23.9M 2020 +94% 2021: $2.1M $2.1M 2021 2022: -$82.3M -$82.3M 2022 2023: -$162.8M -$162.8M 2023 +98% Revenue10 11 4 $32.5M in Q3 FY2024−16% since Q1 FY2024 0 $10.0M $20.0M $30.0M $40.0M Q1 FY2024: $38.8M $38.8M Q1 FY2024 Q2 FY2024: $34.4M $34.4M Q2 FY2024 −11% Q3 FY2024: $32.5M $32.5M Q3 FY2024 −5% Gross profit10 11 4 $1.8M in Q3 FY2024−85% since Q1 FY2024 0 $5.0M $10.0M $15.0M Q1 FY2024: $12.4M $12.4M Q1 FY2024 Q2 FY2024: $7.6M $7.6M Q2 FY2024 −38% Q3 FY2024: $1.8M $1.8M Q3 FY2024 −76% Operating income10 11 4 -$36.2M in Q3 FY2024+86% since Q1 FY2024 -$40.0M -$30.0M -$20.0M -$10.0M 0 Q1 FY2024: -$19.4M -$19.4M Q1 FY2024 Q2 FY2024: -$21.8M -$21.8M Q2 FY2024 +12% Q3 FY2024: -$36.2M -$36.2M Q3 FY2024 +66% Net income10 11 4 -$39.0M in Q3 FY2024+71% since Q1 FY2024 -$40.0M -$30.0M -$20.0M -$10.0M 0 Q1 FY2024: -$22.8M -$22.8M Q1 FY2024 Q2 FY2024: -$24.7M -$24.7M Q2 FY2024 +8% Q3 FY2024: -$39.0M -$39.0M Q3 FY2024 +58% Fiscal year 2017 2018 2019 2020 2021 2022 2023 Revenue $151.5M5 $162.7M6 $181.7M7 $147.7M8 $231.3M3 $252.4M3 $212.4M3 Cost of revenue $65.4M5 $82.3M6 $83.5M7 $71.9M8 $98.2M3 $112.6M3 $170.9M3 Gross profit $86.1M9 $80.4M6 $98.2M7 $75.8M8 $133.1M3 $139.8M3 $41.5M3 Research and development $12.9M9 $14.4M6 $15.1M7 $14.3M8 $21.6M3 $25.2M3 $21.4M3 Operating income $11.1M9 -$13.4M6 -$12.1M7 -$22.8M8 $1.8M3 -$38.2M3 -$156.2M3 Income tax -$18.0M9 $17.3M6 $85.0K7 $470.0K8 $1.3M3 $1.6M3 $1.5M3 Net income $30.0M9 -$30.8M6 -$12.3M7 -$23.9M3 $2.1M3 -$82.3M3 -$162.8M4 Earnings per share $2.169 -$2.239 -$0.887 -$1.438 $0.123 -$4.393 -$8.193 Earnings per share (diluted) $2.049 -$2.239 -$0.887 -$1.438 $0.113 -$4.393 -$8.193
Total assets12 9 6 7 8 3 $346.3M in 2023+211% since 2017 0 $200.0M $400.0M $600.0M 2017: $111.2M $111.2M 2017 2018: $97.6M $97.6M 2018 −12% 2019: $113.7M $113.7M 2019 +16% 2020: $132.7M $132.7M 2020 +17% 2021: $280.3M $280.3M 2021 +111% 2022: $521.0M $521.0M 2022 +86% 2023: $346.3M $346.3M 2023 −34% Total liabilities12 9 6 7 8 3 $518.1M in 2023+1018% since 2017 0 $200.0M $400.0M $600.0M 2017: $46.3M $46.3M 2017 2018: $51.3M $51.3M 2018 +11% 2019: $67.8M $67.8M 2019 +32% 2020: $75.9M $75.9M 2020 +12% 2021: $223.7M $223.7M 2021 +195% 2022: $536.2M $536.2M 2022 +140% 2023: $518.1M $518.1M 2023 −3% Shareholders’ equity6 7 8 3 -$171.8M in 2023-$200.0M -$100.0M 0 $100.0M 2017: $64.9M $64.9M 2017 2018: $46.4M $46.4M 2018 −29% 2019: $45.9M $45.9M 2019 −1% 2020: $56.9M $56.9M 2020 +24% 2021: $56.6M $56.6M 2021 −1% 2022: -$15.2M -$15.2M 2022 2023: -$171.8M -$171.8M 2023 +1032% Cash9 6 7 8 3 $143.6M in 2023+912% since 2017 0 $50.0M $100.0M $150.0M $200.0M 2017: $14.2M $14.2M 2017 2018: $26.1M $26.1M 2018 +84% 2019: $26.3M $26.3M 2019 +1% 2020: $47.0M $47.0M 2020 +79% 2021: $164.2M $164.2M 2021 +249% 2022: $145.9M $145.9M 2022 −11% 2023: $143.6M $143.6M 2023 −2% Long-term debt6 $3.6M in 20200 $1.0M $2.0M $3.0M $4.0M 2019: $0 $0 2019 2020: $3.6M $3.6M 2020 Total assets10 11 4 $234.4M in Q3 FY2024−25% since Q1 FY2024 0 $100.0M $200.0M $300.0M $400.0M Q1 FY2024: $312.0M $312.0M Q1 FY2024 Q2 FY2024: $276.3M $276.3M Q2 FY2024 −11% Q3 FY2024: $234.4M $234.4M Q3 FY2024 −15% Total liabilities10 11 4 $487.3M in Q3 FY2024−3% since Q1 FY2024 0 $200.0M $400.0M $600.0M Q1 FY2024: $504.6M $504.6M Q1 FY2024 Q2 FY2024: $492.0M $492.0M Q2 FY2024 −2% Q3 FY2024: $487.3M $487.3M Q3 FY2024 −1% Shareholders’ equity10 11 4 -$252.9M in Q3 FY2024+31% since Q1 FY2024 -$300.0M -$200.0M -$100.0M 0 Q1 FY2024: -$192.6M -$192.6M Q1 FY2024 Q2 FY2024: -$192.6M -$192.6M Q2 FY2024 +0% Q2 FY2024: -$215.7M -$215.7M Q2 FY2024 +12% Q3 FY2024: -$215.7M -$215.7M Q3 FY2024 +0% Q3 FY2024: -$252.9M -$252.9M Q3 FY2024 +17% Cash10 11 4 $57.6M in Q3 FY2024−45% since Q1 FY2024 0 $50.0M $100.0M $150.0M Q1 FY2024: $105.4M $105.4M Q1 FY2024 Q2 FY2024: $83.1M $83.1M Q2 FY2024 −21% Q3 FY2024: $57.6M $57.6M Q3 FY2024 −31% Fiscal year 2017 2018 2019 2020 2021 2022 2023 Cash $14.2M9 $26.1M9 $26.3M6 $47.0M7 $164.2M8 $145.9M3 $143.6M3 Current assets $88.4M12 $87.2M9 $95.0M6 $106.3M7 $249.7M8 $451.2M3 $269.2M3 Total assets $111.2M12 $97.6M9 $113.7M6 $132.7M7 $280.3M8 $521.0M3 $346.3M3 Current liabilities $43.3M12 $47.6M9 $58.6M6 $54.4M7 $73.9M8 $105.8M3 $87.7M3 Long-term debt $06 $3.6M6 Total liabilities $46.3M12 $51.3M9 $67.8M6 $75.9M7 $223.7M8 $536.2M3 $518.1M3 Shareholders’ equity $64.9M6 $46.4M7 $45.9M8 $56.9M3 $56.6M3 -$15.2M3 -$171.8M3 Shares outstanding 13.5M shares12 14.0M shares9 14.3M shares6 17.7M shares7 18.0M shares8 19.7M shares3 20.0M shares3
Cash from operations9 6 7 8 3 -$137.9M in 2023-$150.0M -$100.0M -$50.0M 0 $50.0M 2017: $14.3M $14.3M 2017 2018: $308.0K $308.0K 2018 −98% 2019: -$2.2M -$2.2M 2019 2020: -$16.9M -$16.9M 2020 +664% 2021: $1.2M $1.2M 2021 2022: -$67.0M -$67.0M 2022 2023: -$137.9M -$137.9M 2023 +106% Capital spending9 6 7 8 3 $33.0M in 2023+3761% since 2017 0 $10.0M $20.0M $30.0M $40.0M 2017: $855.0K $855.0K 2017 2018: $1.5M $1.5M 2018 +74% 2019: $991.0K $991.0K 2019 −33% 2020: $1.3M $1.3M 2020 +29% 2021: $1.0M $1.0M 2021 −21% 2022: $22.7M $22.7M 2022 +2136% 2023: $33.0M $33.0M 2023 +45% Free cash flow9 6 7 8 3 -$170.9M in 2023-$200.0M -$150.0M -$100.0M -$50.0M 0 $50.0M 2017: $13.4M $13.4M 2017 2018: -$1.2M -$1.2M 2018 2019: -$3.2M -$3.2M 2019 +172% 2020: -$18.2M -$18.2M 2020 +468% 2021: $220.0K $220.0K 2021 2022: -$89.7M -$89.7M 2022 2023: -$170.9M -$170.9M 2023 +91% Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2017 2018 2019 2020 2021 2022 2023 Cash from operations $14.3M9 $308.0K6 -$2.2M7 -$16.9M8 $1.2M3 -$67.0M3 -$137.9M3 Capital spending $855.0K9 $1.5M6 $991.0K7 $1.3M8 $1.0M3 $22.7M3 $33.0M3 Free cash flow $13.4M -$1.2M -$3.2M -$18.2M $220.0K -$89.7M -$170.9M Share buybacks $35.2M9
Compare CUTERA INC with another company
Former names
ALTUS MEDICAL INC Feb 12, 2002 to Jun 14, 20022
Recent filings
Mar 10, 2025 8-K Mar 7, 2025 8-K Mar 5, 2025 8-K Feb 21, 2025 4 Feb 21, 2025 4 Feb 19, 2025 3 Feb 18, 2025 8-K Feb 4, 2025 4 Jan 3, 2025 4 Dec 3, 2024 4 Dec 2, 2024 8-K Nov 22, 2024 8-K Nov 15, 2024 4 Nov 13, 2024 4 Nov 12, 2024 10-Q Every filing from the last three years, summarized . The full record is on SEC EDGAR.1
